957
Participants
Start Date
October 23, 2019
Primary Completion Date
February 16, 2023
Study Completion Date
February 16, 2023
MT10109L Dose 1
MT10109L Dose 1 will be injected into the GL area
MT10109L Dose 2
MT10109L Dose 2 will be injected into the LCL area
MT10109L Dose 1 + Dose 2
MT10109L Dose 1 will be injected into the GL area plus MT10109L Dose 2 will be injected into the LCL area
UZ Brussel, Jette
Medical Skincare, Sint-Truiden
Skin Search of Rochester Inc., Rochester
MD Laser Skin & Vein, Hunt Valley
SkinDC, Arlington
Virginia Clinical Research, Inc., Norfolk
Wilmington Dermatology Center, Wilmington
Privatpraxis Dr. Hilton & Partner, Düsseldorf
Aventiv Research Dublin, Dublin
MediCorium Zentrum fuer Dermatologie und Aesthetik, Oberursel
Rosenpark Research, Darmstadt
Coleman Center For Cosmetic Dermatologic Surgery, Metairie
Bellaire Dermatology, Bellaire
DermResearch Inc., Austin
Hautok and Hautok-cosmetics, München
Studienzentrum Theatiner46, München
Medical Center Capital - Zdorovie LLC, Moscow
Center dermatovenereology and cosmetology, Moscow
State Budget Institution of Higher Education North, Saint Petersburg
Kazan State Medical University, Kazan'
Clear Dermatology & Aesthetics Center, Scottsdale
The Eye Research Foundation, Newport Beach
Art of Skin MD, Solana Beach
Susan H. Weinkle, Bradenton
Skin Research Institute, Coral Gables
Etre Cosmetic Dermatology and Laser Center, New Orleans
Laser & Skin Surgery Center of New York, New York
M3 Wake Research Inc., Raleigh
Westlake Dermatology & Cosmetic Surgery - Westlake, Austin
Dr. Shannon Humphrey Inc., Vancouver
Project Skin MD LTD, Vancouver
Pacific Derm, Vancouver
Dermetics Cosmetic Dermatology, Burlington
The Center For Dermatology, Richmond Hill
Sweat Clinics of Canada, Toronto
Meyer Clinic, Chichester
NHS Lanarkshire, Glasgow
MediZen Premier Aesthetic Clinic, Sutton Coldfield
Medy-Tox
INDUSTRY